Skip to content

Pacific Biosciences of California PACB Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Illumina logo
IlluminaILMN
Agilent Technologies logo
Agilent TechnologiesA
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
Azenta logo
AzentaAZTA
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's finite-lived intangible assets, accumulated amortization?
Pacific Biosciences of California (PACB) reported finite-lived intangible assets, accumulated amortization of $407.44M in Q1 2026.
How has Pacific Biosciences of California's finite-lived intangible assets, accumulated amortization changed year-over-year?
Pacific Biosciences of California's finite-lived intangible assets, accumulated amortization increased by 1.0% year-over-year, from $403.36M to $407.44M.
What is the long-term trend for Pacific Biosciences of California's finite-lived intangible assets, accumulated amortization?
Over 4 years (2021 to 2025), Pacific Biosciences of California's finite-lived intangible assets, accumulated amortization has grown at a 471.5% compound annual growth rate (CAGR), from $381K to $406.42M.